Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer

James J Lee, Justin Huang, Christopher G England, Lacey R McNally and Hermann B Frieboes

PLOS Computational Biology, 2013, vol. 9, issue 9, 1-9

Abstract: A clear contradiction exists between cytotoxic in-vitro studies demonstrating effectiveness of Gemcitabine to curtail pancreatic cancer and in-vivo studies failing to show Gemcitabine as an effective treatment. The outcome of chemotherapy in metastatic stages, where surgery is no longer viable, shows a 5-year survival

Date: 2013
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1003231 (text/html)
https://journals.plos.org/ploscompbiol/article/fil ... 03231&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pcbi00:1003231

DOI: 10.1371/journal.pcbi.1003231

Access Statistics for this article

More articles in PLOS Computational Biology from Public Library of Science
Bibliographic data for series maintained by ploscompbiol ().